Barentz Strengthens Asia Pacific Pharma Team with David Wei

David brings more than 20–25 years of experience in the Pharmaceutical and Nutraceutical industries, with a strong focus on Asia Pacific - including China, Southeast Asia, Australia, New Zealand, and Bangladesh.

author-image
SMEStreet Edit Desk
New Update
David Wei

David Wei

Listen to this article
0.75x1x1.5x
00:00/ 00:00
Barentz, a leading global specialty ingredients solutions provider, is pleased to announce the appointment of David Wei as Vice President Pharma, Asia Pacific. This strategic appointment reflects Barentz’s continued commitment to strengthening its leadership and accelerating growth across the Asia Pacific region.
David brings more than 20–25 years of experience in the Pharmaceutical and Nutraceutical industries, with a strong focus on Asia Pacific - including China, Southeast Asia, Australia, New Zealand, and Bangladesh. He has held senior leadership roles that contributed to significant regional growth through strategic market development, team leadership, and strong partnerships with distributors and industry stakeholders. His deep expertise in excipients and delivery systems has been built over decades, including more than 15 years in general management roles and earlier hands-on experience in technical sales across key markets in the region.
David holds a Doctorate in Business Administration from United Business Institute in Belgium and a Master’s degree in Business Administration from Kedge Business School in France.
Anthony Litchfield, Global VP Pharma in Barentz, commented: “David’s deep understanding of the Asia Pacific’s pharmaceutical landscape, combined with his proven ability to drive commercial growth and build strong partnerships, makes him a valuable addition to our leadership team. We are confident he will play a pivotal role in accelerating our pharma strategy across the region.”
Pharma Barentz